The Ebola epidemic in the Democratic Republic of the Congo has reached what ground-level observers describe as a crisis point in Bunia, the capital of Ituri Province, with 782 confirmed cases and 181 deaths reported nationally as of 13 June and the situation described as out of control [8]. A WHO weekly situation report dated 14 June recorded 808 cumulative confirmed cases and 192 deaths across 31 health zones in three provinces, with 258 new confirmed cases and 91 new deaths in the preceding week alone [6]. The U.S. Centers for Disease Control and Prevention reported the same DRC totals and listed 19 confirmed cases and two deaths in Uganda as of 16 June [14]; the WHO weekly situation report recorded a cumulative total of 20 cases in Uganda [6].
Africa CDC Director-General Jean Kaseya stated that the outbreak could become the worst Ebola epidemic ever recorded, surpassing the 2014–2016 West Africa crisis. "If we don't stop the outbreak very soon it will be worse than what we had in West Africa and eastern DRC," Kaseya said, adding that contact tracing was reaching only 12 percent of identified contacts [5]. A joint Africa CDC–WHO six-month response plan requires $518 million, and officials warned that without rapid mobilization the cost would rise to billions [20]. South Africa's President Cyril Ramaphosa announced a pledge increase to $13.5 million [5]. The WHO weekly report placed contact tracing follow-up coverage at 63.1 percent nationally [6], while Oxfam's field coordinator in Ituri, Manel Rebordosa, said the figure had dropped to 43 percent in some areas, meaning the true scale of the epidemic is likely higher than official numbers suggest [2].
Severe water and sanitation deficits are compounding transmission. Rebordosa stated: "Water, the absolute first line of defense in any public health emergency, is simply not available" [2]. Only 20 percent of residents in Mongbwalu, one of the hardest-hit health zones, have access to clean water [2]. Radio Okapi reported that nearly 30,000 displaced people in camps around Bunia lack handwashing stations and adequate water points [18]. Global humanitarian funding for the DRC has declined by 46 percent, according to Oxfam data cited by CGTN [2].
Community mistrust of the response remains a central obstacle. WHO spokesperson Tarik Jašarević said there are "blind spots where we get a low number of alerts" and that "there may be transmission chains that are not being detected" [7]. Bruno Michon, operations manager for the International Federation of Red Cross and Red Crescent Societies, described trust-building as "lifesaving" rather than optional, noting that some communities question whether Ebola is real and view safe burials as an attack on their culture. "But in this outbreak, it is not optional. It is lifesaving," Michon said [7]. IFRC teams have faced verbal abuse, threats, and physical attacks [5]. RFI reported that in the Logo health zone, families have refused hospitalization and safe burials, slowing containment efforts [9]. Religious leaders in Goma and other areas have used their influence to educate followers, combat rumors, and encourage prevention measures, according to BBC Afrique [22]. Gavi reported that misinformation continues to hinder the response across Ituri, with active hotspots in Bunia, Rwampara, Mongbwalu, and Nyankunde [10].
Armed conflict in Ituri Province adds a further layer of difficulty. Human Rights Watch documented attacks by armed groups and security forces on hospitals, clinics, and health workers, as well as looting of medical supplies [16]. WHO warned that conflict, mass displacement, and poor infrastructure create conditions where transmission chains go undetected [17]. UN News reported that the outbreak is unfolding amid intense armed conflict and severe food insecurity, making contact tracing and case isolation nearly impossible in parts of Ituri and North Kivu [17].
No licensed vaccine or treatment exists for the Bundibugyo strain of Ebola driving this outbreak. WHO-convened experts identified two leading candidates: rVSV Bundibugyo, developed by IAVI, which requires seven to nine months before clinical trial readiness, and ChAdOx1 Bundibugyo, developed by Oxford and the Serum Institute of India, which could be ready in two to three months [13]. Le Monde reported on the scientific, logistical, and funding challenges to advancing any candidate [19]. Médecins Sans Frontières noted that existing GeneXpert diagnostic systems cannot detect the Bundibugyo strain, requiring strain-specific PCR in high-biosafety laboratories, and that 3,000 sets of personal protective equipment recently arrived in Bunia [21].
The DRC government has presented its response as organized and accelerating. An official communiqué from the Prime Minister's office described strategic coordination meetings, deployment of response teams, logistics mobilization, and the planned reopening of Bunia airport to facilitate aid delivery [11]. A joint DRC government–WHO statement outlined intensified surveillance, laboratory analysis, and care measures [12]. Uganda's Ministry of Health has intensified screening at 22 points of entry, including Entebbe International Airport, and no new cases have been reported in Uganda since 5 June [15][6].
Separately, a planned U.S.-backed Ebola quarantine facility in Laikipia, Kenya, has drawn protests in which three people, including a 17-year-old, have been killed [1]. David Kyule, a professor of history and archaeology at the University of Nairobi, stated that the project reinforces "the perception that Kenyan territory remains available for strategic foreign purposes" [1]. Kelvin Kubai, an advocate of the High Court of Kenya, compared the agreement to the 1904 and 1911 Maasai agreements that "surrendered the vast rich savannah grazing lands of Laikipia to foreign interests" [1]. Kenya's Health Cabinet Secretary Aden Duale defended the project, stating: "Under the Public Health Act, we don't need to do public participation; we are not going to consult citizens… This epidemic does not require any consultation" [1].
The WHO weekly situation report noted that the outbreak has not yet peaked [6]. Michon said the IFRC is preparing for the possibility that the epidemic could last one year [5]. The next expected milestone is the potential start of clinical trials for the ChAdOx1 Bundibugyo vaccine candidate within two to three months [13].